Low-dose Quadruple Combination Therapy in Patients With Hypertension
Status:
Not yet recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
This study aims to compare the antihypertensive effect of initial treatment with a single
capsule containing quadruple combination of half-dose of blood pressure medicines or standard
dose dual combination in patients with hypertension.
Phase:
Phase 4
Details
Lead Sponsor:
The Third Xiangya Hospital of Central South University